MARKET

LAB

LAB

STANDARD BIOTOOLS INC
NASDAQ
1.100
-0.030
-2.65%
After Hours: 1.100 0 0.00% 16:49 09/30 EDT
OPEN
1.150
PREV CLOSE
1.130
HIGH
1.156
LOW
1.080
VOLUME
228.28K
TURNOVER
0
52 WEEK HIGH
6.67
52 WEEK LOW
1.080
MARKET CAP
86.52M
P/E (TTM)
-0.5210
1D
5D
1M
3M
1Y
5Y
Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted equity awards effecti...
GlobeNewswire · 08/25 20:05
Is Standard BioTools (NASDAQ:LAB) Using Debt In A Risky Way?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Simply Wall St. · 08/14 14:38
Standard BioTools Q2 EPS $(0.33) Down From $(0.12) YoY, Sales $18.78M Miss $26.50M Estimate
Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.33) per share. This is a 175 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of
Benzinga · 08/08 21:17
Standard BioTools Non-GAAP EPS of -$0.33, revenue of $18.78M
Standard BioTools press release (<span class="tic...
Seekingalpha · 08/08 20:48
-- Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q2 Revenue $18.8M
-- Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q2 Revenue $18.8M
MT Newswires · 08/08 16:21
Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results
SOUTH SAN FRANCISCO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today announced that it will report second quarter 2022 financial ...
GlobeNewswire · 07/25 20:30
Shareholders in Standard BioTools (NASDAQ:LAB) have lost 86%, as stock drops 12% this past week
As an investor, mistakes are inevitable. But really bad investments should be rare. So spare a thought for the long...
Simply Wall St. · 07/04 15:56
Insiders Buy More Than $3M Of 3 Penny Stocks
US stock futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inter...
Benzinga · 06/07 11:55
More
About LAB
Standard BioTools Inc. is focused on unleashing tools to accelerate breakthroughs in human health. The Company has a portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines. It provides reliable and repeatable insights into health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on translational and clinical research, including oncology, immunology, and immunotherapy. The Company offers instruments, such as Access Array, AccuLift, Biomark HD, Biomark X, C1, CyTOF XT, Flow Conductor, Helios a CyTOF System, Hyperion Imaging System, Hyperion+ Imaging System, and Juno. It distributes its systems through its direct sales force and support organizations.

Webull offers kinds of Standard Biotools Inc stock information, including NASDAQ:LAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LAB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LAB stock methods without spending real money on the virtual paper trading platform.